• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

涉及脑血管异常在阿尔茨海默病的发病机制和进展:一种肾上腺素能的方法。

Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer's disease: an adrenergic approach.

机构信息

Liaoning Provincial Center for Clinical Research on Neurological Diseases, The First Affiliated Hospital, Dalian Medical University, Dalian 116021, China.

Liaoning Provincial Key Laboratory for Research on the Pathogenic Mechanisms of Neurological Diseases, The First Affiliated Hospital, Dalian Medical University, Dalian 116021, China.

出版信息

Aging (Albany NY). 2021 Sep 3;13(17):21791-21806. doi: 10.18632/aging.203482.

DOI:10.18632/aging.203482
PMID:34479211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8457611/
Abstract

Alzheimer's disease (AD), as the most common neurodegenerative disease in elder population, is pathologically characterized by β-amyloid (Aβ) plaques, neurofibrillary tangles composed of highly-phosphorylated tau protein and consequently progressive neurodegeneration. However, both Aβ and tau fails to cover the whole pathological process of AD, and most of the Aβ- or tau-based therapeutic strategies are all failed. Increasing lines of evidence from both clinical and preclinical studies have indicated that age-related cerebrovascular dysfunctions, including the changes in cerebrovascular microstructure, blood-brain barrier integrity, cerebrovascular reactivity and cerebral blood flow, accompany or even precede the development of AD-like pathologies. These findings may raise the possibility that cerebrovascular changes are likely pathogenic contributors to the onset and progression of AD. In this review, we provide an appraisal of the cerebrovascular alterations in AD and the relationship to cognitive impairment and AD pathologies. Moreover, the adrenergic mechanisms leading to cerebrovascular and AD pathologies were further discussed. The contributions of early cerebrovascular factors, especially through adrenergic mechanisms, should be considered and treasured in the diagnostic, preventative, and therapeutic approaches to address AD.

摘要

阿尔茨海默病(AD)是最常见的老年人群神经退行性疾病,其病理特征为β-淀粉样蛋白(Aβ)斑块、由高度磷酸化的 tau 蛋白组成的神经原纤维缠结以及随后的进行性神经退行性变。然而,Aβ和 tau 都不能涵盖 AD 的整个病理过程,并且大多数基于 Aβ或 tau 的治疗策略都失败了。越来越多的临床和临床前研究证据表明,与年龄相关的脑血管功能障碍,包括脑血管微观结构、血脑屏障完整性、脑血管反应性和脑血流的变化,与 AD 样病理的发展相伴或甚至先于其发展。这些发现可能提示脑血管变化很可能是 AD 发病和进展的致病因素。在这篇综述中,我们评估了 AD 中的脑血管改变及其与认知障碍和 AD 病理的关系。此外,还进一步讨论了导致脑血管和 AD 病理的肾上腺素能机制。在 AD 的诊断、预防和治疗方法中,应考虑并重视早期脑血管因素的作用,尤其是通过肾上腺素能机制的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8457611/288043bcadbd/aging-13-203482-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8457611/fab7301d8360/aging-13-203482-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8457611/288043bcadbd/aging-13-203482-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8457611/fab7301d8360/aging-13-203482-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/8457611/288043bcadbd/aging-13-203482-g002.jpg

相似文献

1
Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer's disease: an adrenergic approach.涉及脑血管异常在阿尔茨海默病的发病机制和进展:一种肾上腺素能的方法。
Aging (Albany NY). 2021 Sep 3;13(17):21791-21806. doi: 10.18632/aging.203482.
2
Alzheimer's Disease and Vascular Aging: JACC Focus Seminar.阿尔茨海默病与血管老化:美国心脏病学会焦点研讨会
J Am Coll Cardiol. 2020 Mar 3;75(8):942-951. doi: 10.1016/j.jacc.2019.10.062.
3
Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.利用先进的癌症疗法在阿尔茨海默病的临床前模型中逆转病理学:通过攻击脑血管新血管生成。
EBioMedicine. 2021 Sep;71:103503. doi: 10.1016/j.ebiom.2021.103503. Epub 2021 Sep 15.
4
Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade.阿尔茨海默病、脑血管病和β-淀粉样蛋白级联反应。
Can J Neurol Sci. 2012 Nov;39(6):712-28. doi: 10.1017/s0317167100015547.
5
Linking Cerebrovascular Dysfunction to Age-Related Hearing Loss and Alzheimer's Disease-Are Systemic Approaches for Diagnosis and Therapy Required?将脑血管功能障碍与年龄相关性听力损失和阿尔茨海默病联系起来——是否需要系统的诊断和治疗方法?
Biomolecules. 2022 Nov 19;12(11):1717. doi: 10.3390/biom12111717.
6
Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy.脑血管疾病与阿尔茨海默病的病理生理学。对治疗的启示。
Panminerva Med. 2004 Dec;46(4):239-51.
7
[Vascular factors in the pathogenesis of Alzheimer's disease].[阿尔茨海默病发病机制中的血管因素]
Nervenarzt. 2013 Jun;84(6):732-7. doi: 10.1007/s00115-013-3800-1.
8
A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review.完美风暴:哺乳动物雷帕霉素靶蛋白(mTOR)在阿尔茨海默病脑血管功能障碍中的作用:综述。
Gerontology. 2018;64(3):205-211. doi: 10.1159/000485381. Epub 2018 Jan 11.
9
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
10
New therapeutic targets in the neurovascular pathway in Alzheimer's disease.阿尔茨海默病神经血管通路中的新治疗靶点。
Neurotherapeutics. 2008 Jul;5(3):409-14. doi: 10.1016/j.nurt.2008.05.011.

引用本文的文献

1
Navigation Between Alzheimer's Disease (AD) and Its Various Pathophysiological Trajectories: The Pathogenic Link to Neuroimmunology-Genetics and Neuroinflammation.阿尔茨海默病(AD)与其各种病理生理轨迹之间的关联:与神经免疫学-遗传学及神经炎症的致病联系
Int J Mol Sci. 2025 Aug 26;26(17):8253. doi: 10.3390/ijms26178253.
2
Modulation of neuronal α1-adrenergic receptor reduces tauopathy and neuroinflammation by inhibiting the STING/NF-κB/NLRP3 signaling pathway in Alzheimer's disease mice.调节神经元α1-肾上腺素能受体可通过抑制阿尔茨海默病小鼠的STING/NF-κB/NLRP3信号通路来减轻tau蛋白病和神经炎症。
J Neuroinflammation. 2025 Jul 17;22(1):187. doi: 10.1186/s12974-025-03506-3.
3

本文引用的文献

1
Repurposing beta-3 adrenergic receptor agonists for Alzheimer's disease: beneficial effects in a mouse model.β3 肾上腺素能受体激动剂在阿尔茨海默病中的再利用:在小鼠模型中的有益作用。
Alzheimers Res Ther. 2021 May 21;13(1):103. doi: 10.1186/s13195-021-00842-3.
2
Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.阿尔茨海默病:去甲肾上腺素参与的不断发展的认识和电疗疗法的广阔前景。
Clin Transl Med. 2021 Apr;11(4):e397. doi: 10.1002/ctm2.397.
3
2021 Alzheimer's disease facts and figures.
Multi-target approach to Alzheimer's disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms.
阿尔茨海默病预防与治疗的多靶点方法:抗氧化、抗炎和淀粉样蛋白调节机制。
Neurogenetics. 2025 Apr 1;26(1):39. doi: 10.1007/s10048-025-00821-y.
4
Altered copper transport in oxidative stress-dependent brain endothelial barrier dysfunction associated with Alzheimer's disease.与阿尔茨海默病相关的氧化应激依赖性脑内皮屏障功能障碍中铜转运的改变。
Vascul Pharmacol. 2024 Dec;157:107433. doi: 10.1016/j.vph.2024.107433. Epub 2024 Sep 22.
5
Extra-Virgin Olive Oil in Alzheimer's Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies.特级初榨橄榄油与阿尔茨海默病:细胞、动物和临床研究的综合综述。
Int J Mol Sci. 2024 Feb 5;25(3):1914. doi: 10.3390/ijms25031914.
6
Cerebrovascular reactivity in Alzheimer's disease signature regions is associated with mild cognitive impairment in adults with hypertension.阿尔茨海默病特征区域的脑血管反应性与高血压成年人的轻度认知障碍有关。
Alzheimers Dement. 2024 Mar;20(3):1784-1796. doi: 10.1002/alz.13572. Epub 2023 Dec 18.
7
Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies.阿尔茨海默病中的血脑屏障破坏:机制与靶向策略。
Int J Mol Sci. 2023 Nov 14;24(22):16288. doi: 10.3390/ijms242216288.
8
Associations between age, sex, APOE genotype, and regional vascular physiology in typically aging adults.在典型的老年人中,年龄、性别、APOE 基因型与区域性血管生理学之间的关联。
Neuroimage. 2023 Jul 15;275:120167. doi: 10.1016/j.neuroimage.2023.120167. Epub 2023 May 13.
9
Air Pollutant impacts on the brain and neuroendocrine system with implications for peripheral organs: a perspective.空气污染物对大脑和神经内分泌系统的影响及其对周围器官的意义:一种观点。
Inhal Toxicol. 2023 Mar-Apr;35(3-4):109-126. doi: 10.1080/08958378.2023.2172486. Epub 2023 Feb 7.
10
The Protective Effects of Zeaxanthin on Amyloid-β Peptide 1-42-Induced Impairment of Learning and Memory Ability in Rats.玉米黄质对淀粉样β肽1-42诱导的大鼠学习记忆能力损伤的保护作用
Front Behav Neurosci. 2022 Jun 23;16:912896. doi: 10.3389/fnbeh.2022.912896. eCollection 2022.
2021 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2021 Mar;17(3):327-406. doi: 10.1002/alz.12328. Epub 2021 Mar 23.
4
Retinal microvasculature dysfunction is associated with Alzheimer's disease and mild cognitive impairment.视网膜微血管功能障碍与阿尔茨海默病和轻度认知障碍有关。
Alzheimers Res Ther. 2020 Dec 4;12(1):161. doi: 10.1186/s13195-020-00724-0.
5
Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer's disease.阿尔茨海默病小鼠模型中的视网膜毛细血管退化和血视网膜屏障破坏。
Acta Neuropathol Commun. 2020 Nov 23;8(1):202. doi: 10.1186/s40478-020-01076-4.
6
Cerebrovascular disease promotes tau pathology in Alzheimer's disease.脑血管疾病会促进阿尔茨海默病中的tau蛋白病变。
Brain Commun. 2020 Aug 19;2(2):fcaa132. doi: 10.1093/braincomms/fcaa132. eCollection 2020.
7
Ocular Vascular Changes in Mild Alzheimer's Disease Patients: Foveal Avascular Zone, Choroidal Thickness, and ONH Hemoglobin Analysis.轻度阿尔茨海默病患者的眼部血管变化:中心凹无血管区、脉络膜厚度及视盘血红蛋白分析
J Pers Med. 2020 Nov 15;10(4):231. doi: 10.3390/jpm10040231.
8
Afferent and Efferent Visual Markers of Alzheimer's Disease: A Review and Update in Early Stage Disease.阿尔茨海默病的传入和传出视觉标志物:疾病早期的综述与更新
Front Aging Neurosci. 2020 Sep 11;12:572337. doi: 10.3389/fnagi.2020.572337. eCollection 2020.
9
Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.血管功能与 Tau PET 的相关性与整体认知和淀粉样蛋白有关。
J Neurosci. 2020 Oct 28;40(44):8573-8586. doi: 10.1523/JNEUROSCI.1230-20.2020. Epub 2020 Oct 12.
10
The Application of Optical Coherence Tomography Angiography in Cerebral Small Vessel Disease, Ischemic Stroke, and Dementia: A Systematic Review.光学相干断层扫描血管造影术在脑小血管病、缺血性卒中和痴呆中的应用:一项系统评价
Front Neurol. 2020 Sep 10;11:1009. doi: 10.3389/fneur.2020.01009. eCollection 2020.